Biote (BTMD) Operating Expenses (2021 - 2026)

Biote has reported Operating Expenses for 6 years, with the latest figure at $3.1 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses fell 32.19% year-over-year to $3.1 million; the trailing twelve-month figure through Mar 2026 stood at $15.1 million (down 11.89% YoY), and the FY2025 full-year result was $16.6 million, up 1.21% from the prior year.
• Operating Expenses for Q1 2026 stood at $3.1 million, down from $4.1 million in the prior quarter.
• The five-year high for Operating Expenses was $113.7 million in Q2 2022, with the low at $3.1 million in Q1 2026.
• Average Operating Expenses over 5 years is $18.2 million, with a median of $5.2 million recorded in 2024.
• Year-over-year, Operating Expenses surged 28182.73% in 2022 and slumped 86.02% in 2024.
• Tracing BTMD's Operating Expenses over 5 years: stood at $22.1 million in 2022, then rose by 19.19% to $26.3 million in 2023, then sank by 84.68% to $4.0 million in 2024, then grew by 0.99% to $4.1 million in 2025, then decreased by 23.72% to $3.1 million in 2026.
• The last three Operating Expenses figures came in at $3.1 million (Q1 2026), $4.1 million (Q4 2025), and $4.3 million (Q3 2025), per Business Quant data.

Peer Comparison